479 studies found for:    Vaginal Diseases: Clinical Trials
Show Display Options
Download search resultsDownload the search results for:
Vaginal Diseases: Clinical Trials (479 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis;   Herpes Simplex
Intervention: Drug: Carraguard (PC-515)
2 Unknown  Hyaluronic Acid and Vaginal Distress
Condition: Vaginal Disease
Intervention: Other: hyaluronic acid pill
3 Completed
Has Results
Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial
Condition: Bacterial Vaginosis
Interventions: Drug: Vaginal acidifying gel (RepHresh);   Drug: Metronidazole control
4 Completed Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn`s Disease (ALOREVA)
Conditions: Rectovaginal Fistula;   Crohn Disease
Intervention: Drug: Expanded allogenic adipose-derived adult stem cells
5 Completed
Has Results
A Clinical Study to Evaluate the Safety of Ospemifene
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo
6 Completed
Has Results
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 30 mg;   Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Nonhormonal vaginal lubricant
7 Completed
Has Results
A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Placebo;   Drug: Ospemifene 5 mg;   Drug: Ospemifene 15 mg;   Drug: Ospemifene 30 mg
8 Completed Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 10 mcg
9 Completed Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments
Conditions: Bacterial Vaginosis;   Candidiasis;   Vaginitis
Intervention: Drug: tinidazole+fluconazole vs metronidazole+clotrimazole
10 Completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Conditions: Advanced Adult Primary Liver Cancer;   Anaplastic Thyroid Cancer;   Bone Metastases;   Carcinoma of the Appendix;   Distal Urethral Cancer;   Fallopian Tube Cancer;   Gastrinoma;   Glucagonoma;   Inflammatory Breast Cancer;   Insulinoma;   Liver Metastases;   Localized Unresectable Adult Primary Liver Cancer;   Lung Metastases;   Male Breast Cancer;   Malignant Pericardial Effusion;   Malignant Pleural Effusion;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Parathyroid Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Newly Diagnosed Carcinoma of Unknown Primary;   Occult Non-small Cell Lung Cancer;   Pancreatic Polypeptide Tumor;   Primary Peritoneal Cavity Cancer;   Proximal Urethral Cancer;   Pulmonary Carcinoid Tumor;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adrenocortical Carcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Anal Cancer;   Recurrent Bladder Cancer;   Recurrent Breast Cancer;   Recurrent Carcinoma of Unknown Primary;   Recurrent Cervical Cancer;   Recurrent Colon Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Esophageal Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Recurrent Gastric Cancer;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Pancreatic Cancer;   Recurrent Parathyroid Cancer;   Recurrent Prostate Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Small Intestine Cancer;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Thyroid Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Skin Metastases;   Small Intestine Adenocarcinoma;   Somatostatinoma;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Adrenocortical Carcinoma;   Stage III Bladder Cancer;   Stage III Cervical Cancer;   Stage III Colon Cancer;   Stage III Endometrial Carcinoma;   Stage III Esophageal Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Gastric Cancer;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Ovarian Epithelial Cancer;   Stage III Pancreatic Cancer;   Stage III Papillary Thyroid Cancer;   Stage III Prostate Cancer;   Stage III Rectal Cancer;   Stage III Renal Cell Cancer;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IIIA Anal Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Anal Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IV Adrenocortical Carcinoma;   Stage IV Anal Cancer;   Stage IV Bladder Cancer;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Esophageal Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IV Gastric Cancer;   Stage IV Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Pancreatic Cancer;   Stage IV Papillary Thyroid Cancer;   Stage IV Prostate Cancer;   Stage IV Rectal Cancer;   Stage IV Renal Cell Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer;   Stage IVB Vulvar Cancer;   Thyroid Gland Medullary Carcinoma;   Unresectable Extrahepatic Bile Duct Cancer;   Unresectable Gallbladder Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer;   WDHA Syndrome
Interventions: Biological: recombinant interleukin-12;   Biological: ABI-007/carboplatin/trastuzumab
11 Completed
Has Results
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Non-hormonal vaginal lubricant
12 Completed
Has Results
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene (Dose 1);   Drug: Ospemifene (Dose 2);   Drug: Placebo
13 Completed
Has Results
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
Conditions: Atrophy;   Vaginal Diseases
Intervention: Drug: Ospemifene
14 Completed Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 25 mcg
15 Completed Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis
Intervention: Drug: Carraguard (PC-515)
16 Completed Theoretical Compared With hands-on Training of Vaginal Breech Management
Condition: Vaginal Abnormality - Baby Delivered
Interventions: Other: hands-on training;   Other: frontal teaching
17 Unknown  Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Papillomavirus Infections;   Genital Herpes;   Gonorrhea;   Chlamydia Infections;   Syphilis;   Bacterial Vaginosis
Intervention: Procedure: Male circumcision
18 Completed Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 25 mcg
19 Terminated
Has Results
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
Condition: Atrophic Vaginitis
Interventions: Drug: Estriol;   Drug: Estradiol valerate;   Drug: Vanicream Lite
20 Active, not recruiting Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
Conditions: Ductal Breast Carcinoma in Situ;   Breast Cancer, Stage I;   Breast Cancer, Stage II;   Breast Cancer, Stage III
Interventions: Dietary Supplement: omega-3 fatty acid;   Other: placebo;   Behavioral: Questionnaire administration

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years